BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22584721)

  • 1. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2.
    Tavares MR; Toledo SP; Montenegro FL; Moyses RA; Toledo RA; Sekyia T; Cernea CR; Brandão LG
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):149-54. PubMed ID: 22584721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
    Niederle B; Sebag F; Brauckhoff M
    Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.
    Lau GS; Lang BH; Lo CY; Tso A; Garcia-Barcelo MM; Tam PK; Lam KS
    Hong Kong Med J; 2009 Oct; 15(5):326-31. PubMed ID: 19801688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current understanding and management of medullary thyroid cancer.
    Roy M; Chen H; Sippel RS
    Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A; Lorenz K; Dralle H
    Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
    Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma.
    Qi XP; Ying RB; Ma JM; Liu WT; Du ZF; Fei J; Yang CP; Song QZ; Jin HY; Chen ZG; Han JS; Wang JQ; Chen XL; Zhao Y; Lu JJ; Zhang XN
    Fam Cancer; 2012 Mar; 11(1):131-6. PubMed ID: 22068382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
    Jung KY; Kim SM; Kim MJ; Cho SW; Kim BW; Lee YS; Jeong JJ; Nam KH; Chung WY; Lee KE; Chung EJ; Kim HJ; Park DJ; Sung MW; Park CS; Cho BY; Park YJ; Chang HS
    Surgery; 2018 Aug; 164(2):312-318. PubMed ID: 29779869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation in multiple endocrine neoplasia type 2.
    Raue F; Frank-Raue K
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):69-75. PubMed ID: 22584709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.
    Gosnell JE; Sywak MS; Sidhu SB; Gough IR; Learoyd DL; Robinson BG; Delbridge LW
    ANZ J Surg; 2006 Jul; 76(7):586-90. PubMed ID: 16813623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome.
    Lendvai N; Tóth M; Valkusz Z; Bekő G; Szücs N; Csajbók E; Igaz P; Kriszt B; Kovács B; Rácz K; Patócs A
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):85-9. PubMed ID: 22584711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
    Machens A; Lorenz K; Weber F; Dralle H
    Eur J Surg Oncol; 2021 Apr; 47(4):920-923. PubMed ID: 32962888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.
    Machens A; Dralle H
    World J Surg; 2007 May; 31(5):957-68. PubMed ID: 17453286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
    Frisco NA; Gunn AH; Thomas SM; Stang MT; Scheri RP; Kazaure HS
    Surgery; 2023 Jan; 173(1):260-267. PubMed ID: 36150924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.